Th1 and Th17 immune responses to viable Propionibacterium acnes in patients with sarcoidosis

Respiratory Investigation

Volumn 50, Issue 3, 2012, Pages 104-109

  Furusawa, Haruhiko ^a   Suzuki, Yoshimi ^a   Miyazaki, Yasunari ^a   Inase, Naohiko ^a   Eishi, Yoshinobu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Mycobacterium tuberculosis; Propionibacterium acnes; Sarcoidosis; Th1; Th17

Indexed keywords

EARLY SECRETORY ANTIGENIC TARGET 6; INTERLEUKIN 17; INTERLEUKIN 2; MESSENGER RNA;

ADULT; ARTICLE; BCG VACCINATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LUNG SARCOIDOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH17 CELL;

ADULT; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PROPIONIBACTERIUM ACNES; SARCOIDOSIS; TH1 CELLS; TH17 CELLS;

EID: 84875829635     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2012.07.001     Document Type: Article

References (31)

1. Hunninghake G.W., Costabel U., Ando M., et al. ATS/ERS/WASOG statement on sarcoidosis. American thoracic society/european respiratory society/world association of sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16:149-173.
2. Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001, 18:56s-68s.
3. Facco M., Cabrelle A., Teramo A., et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 2011, 66:144-150.
4. Eishi Y., Suga M., Ishige I., et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002, 40:198-204.
5. Kuwahara K., Kitazawa T., Kitagaki H., et al. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci 2005, 38:47-55.
6. Sugisaki H., Yamanaka K., Kakeda M., et al. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci 2009, 55:47-52.
7. Song Z., Marzilli L., Greenlee B.M., et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005, 201:755-767.
8. Ulrichs T., Munk M.E., Mollenkopf H., et al. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol 1998, 28:3949-3958.
9. Oswald-Richter K., Sato H., Hajizadeh R., et al. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1-1101. J Clin Immunol 2010, 30:157-166.
10. Drake W.P., Dhason M.S., Nadaf M., et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 2007, 75:527-530.
11. Ishige I., Eishi Y., Takemura T., et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005, 22:33-42.
12. Sorensen A.L., Nagai S., Houen G., et al. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995, 63:1710-1717.
13. Britten C.M., Meyer R.G., Graf C., et al. Identification of T cell epitopes by the use of rapidly generated mRNA fragments. J Immunol Methods 2005, 299:165-175.
14. Ebe Y., Ikushima S., Yamaguchi T., et al. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:256-265.
15. Tchaptchet S., Kirberg J., Freudenberg N., et al. Innate, antigen-independent role for T cells in the activation of the immune system by Propionibacterium acnes. Eur J Immunol 2010, 40:2506-2516.
16. Webster G.F., Leyden J.J., Musson R.A., et al. Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun 1985, 49:116-121.
17. Allen S.S., Evans W., Carlisle J., et al. Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses. Respir Res 2008, 9:36.
18. Inui N., Suda T., Chida K. Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis. Respir Med 2008, 102:313-315.
19. Milman N., Soborg B., Bo Svendsen C., et al. Quantiferon test for tuberculosis screening in sarcoidosis patients. Scand J Infect Dis 2011, 43:728-735.
20. Horster R., Kirsten D., Gaede K.I., et al. Antimycobacterial immune responses in patients with pulmonary sarcoidosis. Clin Respir J 2009, 3:229-238.
21. Khader S.A., Gopal R. IL-17 in protective immunity to intracellular pathogens. Virulence 2010, 1:423-427.
22. Perona-Wright G., Jenkins S.J., O'Connor R.A., et al. A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo. J Immunol 2009, 182:2808-2815.
23. Khader S.A., Bell G.K., Pearl J.E., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
24. Meeks K.D., Sieve A.N., Kolls J.K., et al. IL-23 is required for protection against systemic infection with Listeria monocytogenes. J Immunol 2009, 183:8026-8034.
25. Hamada S., Umemura M., Shiono T., et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 2008, 181:3456-3463.
26. Khader S.A., Pearl J.E., Sakamoto K., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 2005, 175:788-795.
27. Veltkamp M., Van Moorsel C.H., Rijkers G.T., et al. Toll-like receptor (TLR)-9 genetics and function in sarcoidosis. Clin Exp Immunol 2010, 162:68-74.
28. Milner J.D., Brenchley J.M., Laurence A., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
29. Laurence A., Tato C.M., Davidson T.S., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
30. Meloni F., Solari N., Cavagna L., et al. Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clin Exp Rheumatol 2009, 27:765-772.
31. Lenarczyk A., Helsloot J., Farmer K., et al. Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls. Clin Exp Immunol 2000, 122:41-48.